Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies.
Jennifer VogelLiyong LinCharles B SimoneAbigail T BermanPublished in: Acta oncologica (Stockholm, Sweden) (2017)
DS-PBT results in decreased dose to OARs and may reduce the risk of MCEs compared with IMRT. Long-term follow-up is required to assess for clinical benefit from DS-PBT.